# Imlygic

NDC: 55513-079
Generic name: talimogene laherparepvec
Labeler / Manufacturer: Amgen Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SUSPENSION
Routes: INTRALESIONAL
Marketing started: 20151102

FDA application: BLA125518

## Active ingredients

- TALIMOGENE LAHERPAREPVEC: 100000000 [PFU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-079"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-079
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64ffb680-ea8c-42fc-9649-9e8c0eb77ddb